NCT07519304

Brief Summary

A study to evaluate a needle-free connector (a stopper) featuring anti-reflux technology (to prevent blood from flowing back) for catheters (polyurethane tubes inserted into a vein), with the aim of reducing complications associated with these devices: blockages, infections, pain, etc.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Apr 2026Jan 2027

First Submitted

Initial submission to the registry

April 2, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2027

Last Updated

September 21, 2026

Status Verified

September 1, 2026

Enrollment Period

9 months

First QC Date

April 2, 2026

Last Update Submit

September 17, 2026

Conditions

Keywords

Needleless connector

Outcome Measures

Primary Outcomes (1)

  • Number of participants who experienced device-related adverse events, classified according to CTCAE v5.0.

    Percentage of participants experiencing adverse events following insertion of a long peripheral venous catheter and placement of a needle-free connector featuring neutral fluid displacement and anti-reflux technology (Clave™ Neutron™, Ref. 011-NC139).

    7 days

Secondary Outcomes (1)

  • Number of participants with partial or complete occlusions in long peripheral venous catheters, as assessed using the CINAS scale (UZ Leuven®).

    7 days

Study Arms (2)

Needle-free connector without anti-reflux technology

ACTIVE COMPARATOR

Insertion of a long peripheral venous catheters (PVCs) using the accelerated Seldinger technique (AST), followed by placement of a needle-free connector with neutral fluid displacement and no anti-reflux technology (Microclave® Clear, Ref. 011-MC3302).

Procedure: Needle-free connector with neutral fluid displacement and without anti-reflux technologyDevice: Long peripheral venous catheterOther: Ultrasound scanner

Needle-free connector with anti-reflux technology

EXPERIMENTAL

Insertion of a long PVCs using the AST, followed by placement of a needle-free connector featuring neutral fluid displacement and anti-reflux technology (Clave™ Neutron™, Ref. 011-NC139).

Procedure: Needle-free connector with neutral fluid displacement and equipped with anti-reflux technologyDevice: Long peripheral venous catheterOther: Ultrasound scanner

Interventions

Placement of a needle-free connector with neutral fluid displacement and no anti-reflux technology onto a long PVC.

Needle-free connector without anti-reflux technology

Placement of a needle-free connector featuring neutral fluid displacement and anti-reflux technology onto a long PVC.

Needle-free connector with anti-reflux technology

Placement of a 20-gauge long PVC in an arm vein using the AST.

Needle-free connector with anti-reflux technologyNeedle-free connector without anti-reflux technology

All punctures will be performed under ultrasound guidance.

Needle-free connector with anti-reflux technologyNeedle-free connector without anti-reflux technology

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients requiring placement of a long peripheral venous catheter.
  • Patients who have provided written informed consent.
  • Patients with an expected hospital stay of ≥7 days.

You may not qualify if:

  • \- Inability to place a long peripheral venous catheter in the upper limbs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arnau de Vilanova University Hospital in Lleida

Lleida, Lleida, 25198, Spain

Location

Related Publications (28)

  • Krath J, Fredskilde J, Christensen SK, Baltsen CD, Valentin K, Offersen R, Juhl-Olsen P. The performance and complications of long peripheral venous catheters: A retrospective single-centre study. Acta Anaesthesiol Scand. 2024 Nov;68(10):1463-1470. doi: 10.1111/aas.14517. Epub 2024 Aug 26.

    PMID: 39183695BACKGROUND
  • Goossens GA, De Waele Y, Jerome M, Fieuws S, Janssens C, Stas M, Moons P. Diagnostic accuracy of the Catheter Injection and Aspiration (CINAS) classification for assessing the function of totally implantable venous access devices. Support Care Cancer. 2016 Feb;24(2):755-761. doi: 10.1007/s00520-015-2839-x. Epub 2015 Jul 26.

    PMID: 26209949BACKGROUND
  • U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) v.5.0. Cancer Ther Eval Progr [Internet]. 2017;155. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf

    BACKGROUND
  • Schulz KF, Altman DG, Moher D; Consort Group. [CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (Chinese version)]. Zhong Xi Yi Jie He Xue Bao. 2010 Jul;8(7):604-12. doi: 10.3736/jcim20100702. Chinese.

    PMID: 20619135BACKGROUND
  • Valentino R, Farkas V. Maximizing the Midline [Internet]. AVA. 2015 [cited 2025 Jul 16]. p. 1. Available from: https://nexusmedical.com/wp-content/uploads/2021/04/nexus-medical-poster-25-valentino-farkas-maximizing-the-midline-new-york-methodist-hospital-2015-ava-national-conference.pdf

    BACKGROUND
  • ICU medical. Observational In-Vivo Evaluation of the NeutronTM Needlefree Catheter Patency Device and its Effects on Catheter Occlusions in a Home Care Setting [Internet]. icumed.com; 2011. p. 1-2. Available from: https://www.icumed.com/media/ddqd4cgy/p23-5809_neutron-catheter-patency-and-occlusions-home-care-setting_web.pdf

    BACKGROUND
  • Moureau N, Gorski L, Flynn J, Johnson K. A Systematic Review of Needleless Connector Function and Occlusion Outcomes: Evidence Leading the Way. J Infus Nurs. 2025 Mar-Apr 01;48(2):84-105. doi: 10.1097/NAN.0000000000000578. Epub 2025 Mar 6.

    PMID: 40047605BACKGROUND
  • Nexus medical. Nexus TKO® Technology [Internet]. nexusmedical.com. 2022 [cited 2025 Jul 16]. p. 1-10. Available from: https://nexusmedical.com/tko-technology/

    BACKGROUND
  • ICU medical. ClaveTM NeutronTM: Anti-Reflux Neutral Displacement Needlefree Connector [Internet]. https://www.icumed.com/. 2025 [cited 2025 Jul 16]. p. 1-13. Available from: https://www.icumed.com/products/infusion-therapy/infusion-consumables/iv-connectors/clave-neutron/

    BACKGROUND
  • Brodnik JE, Lieux SM, Serrano-Smith M, Bena JF, Siedlecki SL. PICC Line Occlusions: Implications and Opportunities for Medical-Surgical Nurses. MEDSURG Nurs [Internet]. 2023;32(5):305. Available from: https://www.jannettipublications.com/journal/470987/volume/474881/article/474947

    BACKGROUND
  • Weber Y, Cohn-Schwartz D, Khamis S, Neuberger A, Berger G. Safety and efficacy of a new long peripheral catheter in hospitalized patients - a retrospective observational study. SAGE Open Med. 2025 Apr 29;13:20503121251337197. doi: 10.1177/20503121251337197. eCollection 2025.

    PMID: 40309318BACKGROUND
  • Gilardi E, Giannuzzi R, WoldeSellasie K, Piano A, Pittiruti M, Scoppettuolo G. Mini-midline in difficult intravenous access patients in emergency department: A prospective analysis. J Vasc Access. 2020 Jul;21(4):449-455. doi: 10.1177/1129729819883129. Epub 2019 Oct 24.

    PMID: 31647353BACKGROUND
  • Gilardi E, Grandi T, Giannuzzi R, Valletta F, Fugger S, Mazzaroppi S, Petrucci M, Piano A, Piccioni A, WoldeSellasie K, Sambuco F, Travaglino F. Long peripheral cannula in COVID-19 patients: 769 catheter days experience from a semi-intensive respiratory COVID unit. J Vasc Access. 2024 Mar;25(2):498-503. doi: 10.1177/11297298221115002. Epub 2022 Sep 5.

    PMID: 36065094BACKGROUND
  • Yuan M, Li J, Shao W, Xu C, Luo N, Wang H. Evaluating the impact train-the-trainer program in nurse training for mini-midline catheter insertion. BMC Med Educ. 2025 Mar 17;25(1):389. doi: 10.1186/s12909-025-06975-5.

    PMID: 40091028BACKGROUND
  • Fabiani A, Aversana N, Santoro M, Calandrino D, Liotta P, Sanson G. The longer the catheter, the lower the risk of complications: Results of the HERITAGE study comparing long peripheral and midline catheters. Am J Infect Control. 2024 Nov;52(11):1289-1295. doi: 10.1016/j.ajic.2024.06.019. Epub 2024 Jun 27.

    PMID: 38944156BACKGROUND
  • Fabiani A, Santoro M, Sanson G. The catheter-to-vein ratio at the tip level, not the catheter type, as a risk factor for a catheter failure. A retrospective comparative study of polyurethane midline and long peripheral catheters. Heart Lung. 2023 Jul-Aug;60:39-44. doi: 10.1016/j.hrtlng.2023.02.027. Epub 2023 Mar 8.

    PMID: 36898280BACKGROUND
  • Bahl A, Hang B, Brackney A, Joseph S, Karabon P, Mohammad A, Nnanabu I, Shotkin P. Standard long IV catheters versus extended dwell catheters: A randomized comparison of ultrasound-guided catheter survival. Am J Emerg Med. 2019 Apr;37(4):715-721. doi: 10.1016/j.ajem.2018.07.031. Epub 2018 Jul 19.

    PMID: 30037560BACKGROUND
  • Báez O. Clasificación del Midline: Mini-Midline, Midline y Midline Midclavicular [Internet]. Vygon España. 2024 [cited 2025 Jan 28]. p. 1-10. Available from: https://campusvygon.com/es/clasificacion-del-midline-mini-midline-midline-y-midline-midclavicular/

    BACKGROUND
  • Barton A. The benefits of vascular access service teams. Br J Nurs. 2022 Jul 21;31(14):S3. doi: 10.12968/bjon.2022.31.14.S3. No abstract available.

    PMID: 35856581BACKGROUND
  • Morrow S, DeBoer E, Potter C, Gala S, Alsbrooks K. Vascular access teams: a global outlook on challenges, benefits, opportunities, and future perspectives. Br J Nurs. 2022 Jul 21;31(14):S26-S35. doi: 10.12968/bjon.2022.31.14.S26.

    PMID: 35856587BACKGROUND
  • Corcuera Martinez MI, Aldonza Torres M, Diez Revilla AM, Maali Centeno S, Maneru Oria A, Elizari Roncal I, Ibarra Marin B, Casado Del Olmo MI, Escobedo Romero R, Ferraz Torres M. Impact assessment following implementation of a vascular access team. J Vasc Access. 2022 Jan;23(1):135-144. doi: 10.1177/1129729820984284. Epub 2020 Dec 26.

    PMID: 33356810BACKGROUND
  • Ricou Rios L, Esposito Catala C, Pons Calsapeu A, Adroher Mas C, Andres Martinez I, Nuno Ruiz I, Castella Creus M, Castella Fabregas L, Garcia Quesada MJ, Estrada Cuxart O, Ara Del Rey J, Lopez Segui F. Implementation of a vascular access specialist team in a tertiary hospital: a cost-benefit analysis. Cost Eff Resour Alloc. 2023 Sep 16;21(1):67. doi: 10.1186/s12962-023-00464-6.

    PMID: 37716948BACKGROUND
  • Quinn M, Horowitz JK, Krein SL, Gaston A, Ullman A, Chopra V. The role of hospital-based vascular access teams and implications for patient safety: A multi-methods study. J Hosp Med. 2024 Jan;19(1):13-23. doi: 10.1002/jhm.13253. Epub 2023 Dec 15.

    PMID: 38100201BACKGROUND
  • Kleidon TM, Schults J, Paterson R, Rickard CM, Ullman AJ. Comparison of ultrasound-guided peripheral intravenous catheter insertion with landmark technique in paediatric patients: A systematic review and meta-analysis. J Paediatr Child Health. 2022 Jun;58(6):953-961. doi: 10.1111/jpc.15985. Epub 2022 Apr 20.

    PMID: 35441751BACKGROUND
  • Brescia F, Pittiruti M, Spencer TR, Dawson RB. The SIP protocol update: Eight strategies, incorporating Rapid Peripheral Vein Assessment (RaPeVA), to minimize complications associated with peripherally inserted central catheter insertion. J Vasc Access. 2024 Jan;25(1):5-13. doi: 10.1177/11297298221099838. Epub 2022 May 27.

    PMID: 35633065BACKGROUND
  • Nickel B, Gorski L, Kleidon T, Kyes A, DeVries M, Keogh S, Meyer B, Sarver MJ, Crickman R, Ong J, Clare S, Hagle ME. Infusion Therapy Standards of Practice, 9th Edition. J Infus Nurs. 2024 Jan-Feb 01;47(1S Suppl 1):S1-S285. doi: 10.1097/NAN.0000000000000532. No abstract available.

    PMID: 38211609BACKGROUND
  • Bodenham Chair A, Babu S, Bennett J, Binks R, Fee P, Fox B, Johnston AJ, Klein AA, Langton JA, Mclure H, Tighe SQ. Association of Anaesthetists of Great Britain and Ireland: Safe vascular access 2016. Anaesthesia. 2016 May;71(5):573-85. doi: 10.1111/anae.13360. Epub 2016 Feb 17.

    PMID: 26888253BACKGROUND
  • Registered Nurses'Association of Ontario. Best practice guidelines for Vascular Access [Internet]. Second edi. RNAO, INVESTEN-isciii, editors. International Affaurs & Best Practice Guidelines. Ontario; 2021. 1-167 p. Available from: https://rnao.ca/bpg/guidelines/vascular-access-second-edition.

    BACKGROUND

MeSH Terms

Conditions

Bites and StingsThrombosis

Condition Hierarchy (Ancestors)

PoisoningChemically-Induced DisordersWounds and InjuriesEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Researchers will be responsible for catheter insertion and subsequent data collection; however, patients will be blinded to the type of needle-free connector used (with or without anti-reflux technology). In addition, the results will be evaluated by an independent researcher who is not involved in the data collection process.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: A classic parallel-group design will be used, consisting of an intervention group and a control group. The intervention group will receive catheters fitted with a needle-free connector featuring neutral fluid displacement and anti-reflux technology (Clave™ Neutron™, Ref. 011-NC139), whereas the control group will receive a needle-free connector with neutral fluid displacement but without anti-reflux technology (Microclave® Clear, Ref. 011-MC3302).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 9, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 31, 2027

Last Updated

September 21, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, ICF
Time Frame
They will be available by the end of 2026.
Access Criteria
DOI: 10.17632/jy54dx33pz.1
More information

Locations